explore -WSS

explore

author：leisure time 2025-10-02 01:07:09 - browse：9

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Lack of health data on LGBTQ+ people has serious consequences

WSS

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Readout Newsletter: BridgeBio, Akero, and human embryo models

Involuntary treatment for addiction doesn't work

Stem cell biologist probes earliest stages of human development

Why Talkspace is targeting Medicare, a tricky market

Streamlined flu vaccines recommended by FDA advisory panel

hotspot

explore

entertainment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Stem cell biologist probes earliest stages of human development

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Longer MASH drug regimen improved liver, Akero study finds

How to save PrEP access — and even expand it

Argenx drug significantly slows progression of nerve disorder

Malaria cases in Florida and Texas: Here’s what you need to know

Grail faces three suits alleging harassment, retaliation

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why Talkspace is targeting Medicare, a tricky market

knowledge

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Celiac disease study examines precisely how gluten triggers injury

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

$1 billion proposal to grow Boston, Massachusetts biotech

Families look for replacement for GSK asthma drug Flovent

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

entertainment

focus

leisure time

explore